Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1996-11-29
|
| pubmed:abstractText |
Diabetic retinopathy accounts for most visual loss in the United States among working-age individuals. With appropriate detection, evaluation, and treatment, the risk for severe visual loss from this condition is dramatically reduced. This article details the natural history, pathophysiology, complications, grading, evaluation, and treatment for patients with diabetic retinopathy and discusses potential novel treatment modalities currently under investigation.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0889-8529
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
25
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
271-91
|
| pubmed:dateRevised |
2005-11-16
|
| pubmed:meshHeading |
pubmed-meshheading:8799701-Blindness,
pubmed-meshheading:8799701-Diabetes Complications,
pubmed-meshheading:8799701-Diabetic Retinopathy,
pubmed-meshheading:8799701-Humans,
pubmed-meshheading:8799701-Light Coagulation,
pubmed-meshheading:8799701-Prevalence,
pubmed-meshheading:8799701-Treatment Outcome
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
Diabetic eye disease.
|
| pubmed:affiliation |
Joslin Diabetes Center, Boston, Massachusetts, USA.
|
| pubmed:publicationType |
Journal Article,
Review
|